Health Catalyst to Participate in Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT) Following Investor Meetings
June 4, 2020 8:13 AM EDTCantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $44.00 price target on Health Catalyst Inc. (NASDAQ: HCAT) following investor calls with management. COVID-19 was a key focus for the majority of investors. COVID will likely be a headwind to the company's 2020 and 2021... More
